ArticleCell death & disease2021

LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer.

Shengjie Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.